Diabetic Peripheral Neuropathy
Showing 9926 - 9950 of >10,000
Acute Coronary Syndrome Trial in Seoul (Ticagrelor, Prasugrel)
Completed
- Acute Coronary Syndrome
-
Seoul, Korea, Republic ofKorea University Anam Hospital
Apr 24, 2019
Non-Squamous NSCLC Trial in Worldwide (Atezolizumab, Docetaxel)
Completed
- Non-Squamous Non-Small Cell Lung Cancer
-
Bakersfield, California
- +207 more
Dec 6, 2019
Clinical Algorithm With Turbo-Power Following Treatment of
Completed
- Peripheral Arterial Disease
- Laser Atherectomy
-
Raleigh, North CarolinaRex Hospital
Jul 17, 2019
Osteoporosis Pseudoglioma Trial in Lancaster (Lithium)
Completed
- Osteoporosis Pseudoglioma
-
Lancaster, PennsylvaniaUniversity of Maryland Amish Research Clinic
Oct 31, 2019
Pain Trial in Ankara (Distraction)
Completed
- Pain
- Distraction
-
Ankara, TurkeyAyla Demirtas
May 8, 2019
Fibrocytes in Early and Longstanding Rheumatoid Arthritis
Completed
- Rheumatoid Arthritis
- Synovial biopsy
-
Odense, DenmarkOdense University Hospital
Mar 11, 2019
NSCLC Trial in Worldwide (INC280, Gefitinib)
Completed
- Non-small Cell Lung Cancer
-
Woolloongabba, Queensland, Australia
- +30 more
Mar 12, 2021
Cutaneous Lupus Erythematosus (CLE) Trial in Philadelphia (Lenalidomide)
Completed
- Cutaneous Lupus Erythematosus (CLE)
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania, Department of Dermat
Oct 24, 2019
Immune Response After Pancreatic Cancer Treatment
Terminated
- Pancreatic Cancer
- irreversible electroporation (IRE)
-
Bern, SwitzerlandInselhospital
Feb 25, 2020
Sickle Cell Disease Trial in Washington, Bethesda (Niacin-ER, Placebo, L-NMMA)
Completed
- Sickle Cell Disease
- Niacin-ER
- +3 more
-
Washington, District of Columbia
- +1 more
Sep 3, 2020
Type 2 Diabetes Trial in Seongnam (Initial triple combination, Conventional treatment)
Completed
- Type 2 Diabetes
- Initial triple combination
- Conventional treatment
-
Seongnam, Gyeonggi, Korea, Republic ofSeoul National University Bundang Hospital
Mar 14, 2019
Macular Edema, Diabetic Trial in Jinju, Busan, Daegu (aflibercept)
Unknown status
- Macular Edema, Diabetic
-
Jinju, Gyeongsangnam-do, Korea, Republic of
- +7 more
Feb 27, 2019
Chronic Myeloproliferative Disorders, Secondary Myelofibrosis Trial in Rochester (CC-4047)
Completed
- Chronic Myeloproliferative Disorders
- Secondary Myelofibrosis
-
Rochester, MinnesotaMayo Clinic
Dec 16, 2019
Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (insulin degludec, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec
- insulin glargine
-
Birmingham, Alabama
- +165 more
Apr 30, 2019
Chronic Lymphocytic Leukemia Trial in Houston (Lenalidomide)
Completed
- Chronic Lymphocytic Leukemia
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 29, 2020
Chemerin and Fibroblast Growth Factor 21 as Biomarkers of
Completed
- Periodontal Disease (Diagnosis)
- Diabetes Mellitus, Type 2
- gingival crevicular fluid level
-
Cairo, EgyptFaculty of Dentistry
Jul 12, 2019
Lumbar Spinal Stenosis Trial in Puerto Rico, United States (Non-randomized ACADIA® Facet Replacement System, Randomized ACADIA®
Completed
- Lumbar Spinal Stenosis
- Non-randomized ACADIA® Facet Replacement System
- +2 more
-
Beverly Hills, California
- +28 more
Aug 24, 2020
Diabetic Macular Edema Trial in United States (Dexamethasone intravitreal implant (0.7 mg), Intravitreal anti-VEGF injection)
Completed
- Diabetic Macular Edema
- Dexamethasone intravitreal implant (0.7 mg)
- Intravitreal anti-VEGF injection
-
Bakersfield, California
- +3 more
Jan 29, 2019
Diabetic Foot Ulcer Trial in India (Esmolol Hydrochloride, Only Standard of Care, Vehicle Gel)
Unknown status
- Diabetic Foot Ulcer
- Esmolol Hydrochloride
- +2 more
-
Bangalore, Karnataka, India
- +7 more
Jun 25, 2019
Critical Limb Ischemia Trial in Los Angeles (Evolocumab 140mg/mL Injector 1milliliter (mL) Pen x 3 for a monthly dose of 420 mg
Unknown status
- Critical Limb Ischemia
- Evolocumab 140mg/mL Injector 1milliliter (mL) Pen x 3 for a monthly dose of 420 mg for 12 months.
- Placebo 1 milliliter (mL) Injector Pen x 3 monthly for 12 months
-
Los Angeles, CaliforniaUniversity of Southern California
Mar 9, 2020
Achieving SDAI Remission on Joint Space Outcomes Progression in
Not yet recruiting
- Rheumatoid Arthritis
- Treat to target
- (no location specified)
Mar 27, 2020
Agitation on Recovery From Sedation Trial (Hydroxyzine Hydrochloride, Alprazolam tablet, Placebo)
Unknown status
- Agitation on Recovery From Sedation
- Hydroxyzine Hydrochloride
- +2 more
- (no location specified)
Dec 4, 2019
Adrenomyeloneuropathy Trial in L'Hospitalet de LLobregat (N-acetylcysteine, lipoic acid, vitamin E)
Completed
- Adrenomyeloneuropathy
- N-acetylcysteine
- +2 more
-
L'Hospitalet de LLobregat, Barcelona, SpainHospital Universitari de Bellvitge
Mar 7, 2019